Investigation of diabetes risk factors and complications
Chongqing Diabetes and Its Chronic Complications Registry Study
This study is trying to find out what causes complications in people with diabetes by looking at their health, lifestyle, and test results over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing, Chongqing Municipality) |
| Trial ID | NCT03692884 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the risk factors and biomarkers associated with microvascular and macrovascular diseases, as well as neuropathy in patients with diabetes. Approximately 5000 patients diagnosed with diabetes will be enrolled from the Chongqing Diabetes Centre in China for long-term follow-up. Data will be collected on various parameters including socio-demographic information, medical history, lifestyle factors, and metabolic control indicators, along with blood and urine samples to assess complications. The goal is to better understand the occurrence and development of diabetes-related complications.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with diabetes mellitus who are under 75 years of age.
Not a fit: Patients who are pregnant, breastfeeding, or have chronic diseases requiring long-term glucocorticoid therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and management strategies for diabetes complications.
How similar studies have performed: Other studies have shown success in identifying risk factors and biomarkers for diabetes complications, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of diabetes mellitus（based on the 1999 WHO diagnostic cretirial）; 2. Age younger than 75 years old, gender is not limited; 3. Voluntary to sign on the informed consent. Exclusion Criteria: 1. pregnant or breast-feeding women; 2. Patients with chronic disease requiring long-term glucocorticoid therapy; 3. Patients with severe infection (except for diabetic foot) or immune dysfunction.
Where this trial is running
Chongqing, Chongqing Municipality
- Qifu Li — Chongqing, Chongqing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Qifu Li, phD
- Email: liqifu@yeah.net
- Phone: +86 023-89011552
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.